A strategy to rapidly access an unmet market worth over 10 billion dollars*
Sensorion is aiming to become a major player in the treatment of inner ear pathologies, a large nascent market whose worldwide potential is estimated at over 10 billion dollars*.
Sensorion targets sizeable unmet medical needs, as no drug currently provides an efficient solution to these highly-debilitating pathologies that affect more than 140 million patients worldwide*. Its strategy consists in rapidly developing a diverse portfolio of products that meet this major need thanks to:
(*) Source: Alcimed, Sensorion